MedPath

Homeopathic medicines for treatment of psoriasis

Phase 2
Conditions
Health Condition 1: L400- Psoriasis vulgaris
Registration Number
CTRI/2019/11/021917
Lead Sponsor
ational Institute of Homoeopathy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients suffering from mild to moderate psoriasis (PASI score 20 or less) for 3 months or more

2. Age between 18-65 years

3. Both sexes

4. Patient willing to take part in the study and giving written consent

5. Literate patients; ability to read English and/or Bengali

Exclusion Criteria

1. Severe psoriasis (PASI score more than 20)

2. Patient who are too sick for consultation

3. Unable to read patient information sheets and not giving consent to take part

4. Psoriasis with complications like erythroderma and pustules

5. Diagnosed cases of unstable psychiatric illness or other systemic disease affecting quality of life

6. Currently receiving homeopathic treatment for chronic condition(s)

7. Pregnant and lactating women

8. Self-reported immune-compromised state

9. Substance abuse and/or dependence

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Psoriasis Area Scoring Index (PASI)Timepoint: Baseline, every 2 months, up to 6 months
Secondary Outcome Measures
NameTimeMethod
Dermatological Life Quality Index (DLQI) questionnaire scoreTimepoint: Baseline, every 2 months, up to 6 months;Psoriasis Disability Index (PDI) questionnaire scoreTimepoint: Baseline, every 2 months, up to 6 months
© Copyright 2025. All Rights Reserved by MedPath